ecteinascidin 743 has been researched along with Angiogenesis, Pathologic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allavena, P; Belgiovine, C; Bello, E; Beltrame, L; Craparotta, I; D'Incalci, M; Frapolli, R; Galmarini, CM; Liguori, M; Mannarino, L; Mantovani, A; Marchini, S; Paracchini, L | 1 |
| Guerriero, JL | 1 |
| Allavena, P; Anichini, A; Anselmo, A; Belgiovine, C; Beltrame, L; Casali, PG; D'Incalci, M; Erba, E; Frapolli, R; Fuso Nerini, I; Galmarini, CM; Germano, G; Liguori, M; Mantovani, A; Marchini, S; Mortarini, R; Nebuloni, M; Pasqualini, F; Pesce, S; Pilotti, S; Sanfilippo, R; Uboldi, S; van Rooijen, N; Zucchetti, M | 1 |
| Atmaca, H; Uzunoglu, S | 1 |
| Aglietta, M; Bertotti, A; Capussotti, L; Cavalloni, G; Gammaitoni, L; Leone, F; Marchiò, S; Medico, E; Peraldo-Neia, C; Sassi, F; Soster, M; Trusolino, L | 1 |
| Thornton, K | 1 |
| Allavena, P; Mantovani, A | 1 |
| Blay, JY; Fayette, J; Méeus, P; Ray Coquard, I; Sunyach, MP; Thiesse, P | 1 |
4 review(s) available for ecteinascidin 743 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Macrophages: The Road Less Traveled, Changing Anticancer Therapy.
Topics: Animals; Antineoplastic Agents; Humans; Macrophages; Molecular Targeted Therapy; Neoplasms; Neovascularization, Pathologic; Trabectedin; Tumor Microenvironment | 2018 |
Chemotherapeutic management of soft tissue sarcoma.
Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Dioxoles; Doxorubicin; Humans; Ifosfamide; Neoadjuvant Therapy; Neovascularization, Pathologic; Sarcoma; Tetrahydroisoquinolines; TNF-Related Apoptosis-Inducing Ligand; Trabectedin | 2008 |
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzenesulfonates; Chemotaxis; Clodronic Acid; Cytokines; Dioxoles; Disease Progression; Humans; Immunity, Innate; Inflammation; Liposomes; Macrophages; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Prognosis; Pyridines; Sorafenib; Tetrahydroisoquinolines; Trabectedin; Tumor Escape; Tumor Microenvironment | 2012 |
[News of the year 2005 in sarcomas].
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dioxoles; Genetic Markers; Humans; Isoquinolines; Neovascularization, Pathologic; Patient Care Planning; Prognosis; Sarcoma; Tetrahydroisoquinolines; Trabectedin | 2006 |
4 other study(ies) available for ecteinascidin 743 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Carbolines; Caspase 8; Cell Adhesion; Cell Movement; Chemokine CCL2; Dioxoles; Down-Regulation; Female; Fibrosarcoma; Gene Expression; Gene Expression Profiling; Heterocyclic Compounds, 4 or More Rings; HL-60 Cells; Humans; Interleukin-8; Leukocyte Count; Macrophages; Mice; Mice, Inbred C57BL; Monocytes; Neovascularization, Pathologic; Ovarian Neoplasms; rho GTP-Binding Proteins; Tetrahydroisoquinolines; Trabectedin; Tumor Microenvironment; U937 Cells; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
Role of macrophage targeting in the antitumor activity of trabectedin.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Blotting, Western; Carcinoma, Lewis Lung; Caspase 8; Cell Proliferation; Dioxoles; Female; Fibrosarcoma; Flow Cytometry; Humans; Immunoenzyme Techniques; Macrophages; Mice; Monocytes; Myeloid Cells; Neovascularization, Pathologic; Ovarian Neoplasms; Phagocytes; Signal Transduction; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured | 2013 |
Anti-angiogenic effects of trabectedin (Yondelis; ET-743) on human breast cancer cells.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Dioxoles; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Human Umbilical Vein Endothelial Cells; Humans; Insulin-Like Growth Factor Binding Protein 2; MCF-7 Cells; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1; RNA, Messenger; Tetrahydroisoquinolines; Tissue Inhibitor of Metalloproteinase-1; Trabectedin; Vascular Endothelial Growth Factor A | 2014 |
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Biliary Tract Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dioxoles; DNA Repair; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Histones; Humans; Interleukin-6; Mice; Mice, Inbred NOD; Neovascularization, Pathologic; Phosphorylation; Tetrahydroisoquinolines; Trabectedin; Tumor Suppressor Protein p53; Wnt Signaling Pathway | 2014 |